Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis
Clinical trial NCT02565576 · COMPLETED
Trial details
- NCT number
- NCT02565576
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-29
- Primary completion
- 2017-07-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.